Heteroarylcarbamoylbenzene derivative

Details Heteroarylcarbamoylbenzene derivative Heteroarylcarbamoylbenzene derivative

2004-02-26

2008-10-07

Shiao, Rei-tsang (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S407000, C546S275100, C548S364400

Reexamination Certificate

active

07432287

ABSTRACT:
Compounds represented by formula (I):as well as their pharmaceutically acceptable salts are disclosed. The compounds are useful as glucokinase activating agents for the treatment of diabetes and related conditions. Compositions and methods of treatment are also included.

REFERENCES:
patent: 2005/0080106 (2005-04-01), Boyd et al.
patent: 1 420 784 (2006-04-01), None
patent: 1 661 563 (2006-05-01), None
patent: 1 661 567 (2006-05-01), None
patent: 1 661 568 (2006-05-01), None
patent: 1 661 569 (2006-05-01), None
patent: 1 669 068 (2006-06-01), None
patent: 1 669 069 (2006-06-01), None
patent: 1 674 097 (2006-06-01), None
patent: 1 529 530 (2006-08-01), None
patent: 1 695 705 (2006-08-01), None
patent: 1 568 367 (2007-04-01), None
patent: 0102764-8 (2001-08-01), None
patent: WO 03/000267 (2003-01-01), None
patent: WO 03000267 (2003-01-01), None
patent: WO 03/015774 (2003-02-01), None
AstraZeneca AB, U.S. Appl. No. 12/024,561, filed Feb. 1, 2008.

Affiliated with

Also associated with

Rating

Heteroarylcarbamoylbenzene derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylcarbamoylbenzene derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylcarbamoylbenzene derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4016885